Literature DB >> 22710633

Migraine: new US guidelines for preventive treatment of migraine.

Peer C Tfelt-Hansen1, Anders Hougaard.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22710633     DOI： 10.1038/nrneurol.2012.115

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  9 in total

1.  Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators.

Authors:  Peer Tfelt-Hansen; Julio Pascual; Nabih Ramadan; Carl Dahlöf; Domenico D'Amico; Hans-Christopher Diener; Jakob Møller Hansen; Michel Lanteri-Minet; Elisabeth Loder; Douglas McCrory; Sandra Plancade; Todd Schwedt
Journal:  Cephalalgia       Date:  2012-01       Impact factor: 6.292

2.  Comparison of the effect of topiramate and sodium valporate in migraine prevention: a randomized blinded crossover study.

Authors:  Vahid Shaygannejad; Mohsen Janghorbani; Abbas Ghorbani; Fereshteh Ashtary; Naser Zakizade; Vida Nasr
Journal:  Headache       Date:  2006-04       Impact factor: 5.887

3.  Migraine prevalence, disease burden, and the need for preventive therapy.

Authors:  R B Lipton; M E Bigal; M Diamond; F Freitag; M L Reed; W F Stewart
Journal:  Neurology       Date:  2007-01-30       Impact factor: 9.910

Review 4.  Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.

Authors:  S Holland; S D Silberstein; F Freitag; D W Dodick; C Argoff; E Ashman
Journal:  Neurology       Date:  2012-04-24       Impact factor: 9.910

Review 5.  Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.

Authors:  S D Silberstein; S Holland; F Freitag; D W Dodick; C Argoff; E Ashman
Journal:  Neurology       Date:  2012-04-24       Impact factor: 9.910

Review 6.  Tricyclic antidepressants and headaches: systematic review and meta-analysis.

Authors:  Jeffrey L Jackson; William Shimeall; Laura Sessums; Kent J Dezee; Dorothy Becher; Margretta Diemer; Elizabeth Berbano; Patrick G O'Malley
Journal:  BMJ       Date:  2010-10-20

Review 7.  Propranolol for migraine prophylaxis.

Authors:  K Linde; K Rossnagel
Journal:  Cochrane Database Syst Rev       Date:  2004

8.  EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force.

Authors:  S Evers; J Afra; A Frese; P J Goadsby; M Linde; A May; P S Sándor
Journal:  Eur J Neurol       Date:  2009-09       Impact factor: 6.089

9.  Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment?

Authors:  Rudiger Schellenberg; Albert Lichtenthal; Heike Wöhling; Christine Graf; Klara Brixius
Journal:  Headache       Date:  2008-01       Impact factor: 5.887
  9 in total
  3 in total

1.  Migraine-Related Aural Fullness: A Potential Clinical Entity.

Authors:  Omid Moshtaghi; Yaser Ghavami; Hossein Mahboubi; Ronald Sahyouni; Yarah Haidar; Kasra Ziai; Harrison W Lin; Hamid R Djalilian
Journal:  Otolaryngol Head Neck Surg       Date:  2017-12-05       Impact factor: 3.497

2.  Resolution of Persistent Post-Stapedotomy Vertigo With Migraine Prophylactic Medication.

Authors:  Omid Moshtaghi; Hossein Mahboubi; Yarah M Haidar; Ronald Sahyouni; Harrison W Lin; Hamid R Djalilian
Journal:  Otol Neurotol       Date:  2017-12       Impact factor: 2.311

3.  Outcome of patients with chronic migraine with medication overuse and depression after duloxetine: influence of coexisting obsessive compulsive disorder.

Authors:  Marcella Curone; V Tullo; M Savino; A Proietti-Cecchini; G Bussone; D D'Amico
Journal:  Neurol Sci       Date:  2013-05       Impact factor: 3.307
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.